WO2006075236A1 - Dermal lubricant and moisturiser - Google Patents
Dermal lubricant and moisturiser Download PDFInfo
- Publication number
- WO2006075236A1 WO2006075236A1 PCT/IB2006/000045 IB2006000045W WO2006075236A1 WO 2006075236 A1 WO2006075236 A1 WO 2006075236A1 IB 2006000045 W IB2006000045 W IB 2006000045W WO 2006075236 A1 WO2006075236 A1 WO 2006075236A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lubricant
- percent
- weight
- range
- moisturiser
- Prior art date
Links
- 239000000314 lubricant Substances 0.000 title claims abstract description 38
- 230000002500 effect on skin Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 37
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 28
- 239000010903 husk Substances 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 25
- 241000208202 Linaceae Species 0.000 claims abstract description 22
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 20
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 14
- 230000000840 anti-viral effect Effects 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 9
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 6
- 230000000699 topical effect Effects 0.000 claims abstract description 6
- 239000004615 ingredient Substances 0.000 claims description 16
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 12
- 108010023244 Lactoperoxidase Proteins 0.000 claims description 11
- 102000045576 Lactoperoxidases Human genes 0.000 claims description 11
- 229940057428 lactoperoxidase Drugs 0.000 claims description 11
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid group Chemical group C(C=CC1=CC=CC=C1)(=O)O WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 8
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 7
- 229930016911 cinnamic acid Natural products 0.000 claims description 7
- 235000013985 cinnamic acid Nutrition 0.000 claims description 7
- 239000005711 Benzoic acid Substances 0.000 claims description 6
- 235000010233 benzoic acid Nutrition 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 235000010199 sorbic acid Nutrition 0.000 claims description 4
- 239000004334 sorbic acid Substances 0.000 claims description 4
- 229940075582 sorbic acid Drugs 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 239000010374 citricidal Substances 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229960004889 salicylic acid Drugs 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 229940107702 grapefruit seed extract Drugs 0.000 claims description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims 2
- 229940121357 antivirals Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 239000003755 preservative agent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000001050 lubricating effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 210000004392 genitalia Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000010241 potassium sorbate Nutrition 0.000 description 4
- 239000004302 potassium sorbate Substances 0.000 description 4
- 229940069338 potassium sorbate Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000006172 buffering agent Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 240000007551 Boswellia serrata Species 0.000 description 2
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- TURGQPDWYFJEDY-UHFFFAOYSA-N 1-hydroperoxypropane Chemical group CCCOO TURGQPDWYFJEDY-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940069078 citric acid / sodium citrate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 229940042129 topical gel Drugs 0.000 description 1
- 229940100617 topical lotion Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- This invention relates to an improved lubricant and moisturiser for application to the skin generally and particularly to mucous membranes .
- Liquid compositions are known which may be applied topically to human skin to act as a lubricant or to moisturise it .
- Popular compositions contain a stable mixture of components so as to perform both functions .
- the combined moisturiser and lubricant compositions need to be stabilised, usually as a gel or as an emulsion and also need additives to ensure long-term stability from oxidation and other forms of deterioration .
- Known compositions may form a stable base for infections, bacterial or viral, present on skin and can act as a vector for the infection carrying it to other people .
- This invention provides a liquid and gel lubricants and moisturiser compositions , which, are stable, and does not carry viral and bacterial infections .
- a lubricant and moisturiser composition for topical application comprising an extract of the seed husk of flax (Linum usitatissimum) .
- a lubricant and moisturiser composition for topical application comprising an extract of the seed husk of flax (Linum usitatissimum) in combination with one or more natural and/or nature identical antibacterial, anti-fungal and anti-viral active ingredients .
- the composition can be used as a lubricant due to the lubricant properties of the flax husk extract . It also has the added advantage of providing protection against potentially transmitted infections . Such transmission can easily take place where the areas of one or more users to which the lubricant has been applied come in contact, e . g . during sexual relations .
- the preferred antibacterial , anti-fungal and anti-viral active ingredient is an antibacterial system based on lactoperoxidase alone or in combination with glucose oxidase and a substrate such as glucose .
- Such an ingredient is sold under the trademark Biovert .
- the ingredient is suitably present in a range from 0.5 to 2.5 percent by weight .
- Preferably the total enzyme levels lie in a range of 0.01 to 0.1 percent by weight .
- An alternative antibacterial, anti-fungal and anti-viral active ingredient is Sorbic acid and its sodium and potassium salts .
- Sorbic acid is suitably present in a range 0.05 to 1.5 percent by weight and preferably in the range 0.1 to 0.5 per cent .
- antibacterial , anti-fungal and antiviral ingredients include benzoic acid and its sodium and potassium salts .
- Benzoic acid is suitably present in a range 0.05 to 1.5 percent by weight, preferably 0.1 to 0.5 percent .
- Cinnamic acid id preferably present in a range 0.05 to 0.4 percent by weight .
- Salicylic acid or its soluble salts is suitably present in the range 0.1 to 2 percent, more preferably 0.5 to 1 percent .
- Grapefruit seed extract (sold under a brand name citricidal) in the range of 0.05 to 2.0 percent, more preferably 0.1-0.5 percent .
- the formulations made with the flax husk extract may be compounded in known manner to make a gel, a cream or lotions for topical application to skin .
- xanthan gum 0.2 to 2 percent by weight, or any other suitable gelling agents such as hydroxy ethyl cellulose or hydroxy propyl ether groups may be added as a gelling agent, to thicken it up to the desired viscosity .
- the formulations have excellent moisturising and lubricating capability . They are particularly suitable for use as a lubricant and as a moisturiser on any part of the human body including the lips and genital areas .
- the flax husks contain compounds . in colloidal form which, when extracted in cold or hot water, yield colloidal ingredients with unique properties .
- the extracts are available commercially under the trade marks Natunola flax extract 121 and 141 and 160 from Natunola Health of Canada . However these extracts are preserved with synthetic chemical preservatives .
- lubricant and moisturiser composition the flax husk extract is preserved using natural and/or nature identical ingredients to control bacteria and also to overcome any fungal spores that may be present in the extract .
- the preferred natural and/or nature identical antibacterial system is based on Lactoperoxidase . It is able to provide a protective shield to the user of the products from pathogenic bacteria infections such as staphylococcus aureus, widely found on skin and in genital areas, and fungal infections, such as Candida albicans , found mainly in vaginal areas .
- the Lactoperoxidase is also capable of acting as an anti-viral to give the user of the product a protective shield against these harmful organisms by lowering the population of these organisms by 90% or more within 10 minutes of application and more often within five minutes . It is capable of reducing the population of organisms from several million colony-forming units to a thousand or less colony forming units . This antiseptic property combined with its unique lubricating properties of flax make this combination ideal for use as a sexual aid to give an added protection against potential infections .
- Extraction of flax husk can be carried out as outlined below or commercially extracted flax husks could be utilised and preserved using these natural and nature identical preservatives to give flax husks with unique properties with the added benefit of being naturally preserved yet capable of protecting the skin or genital area from harmful pathogenic organisms .
- Examples are provided showing the manufacture of a topical gel , lotion and cream with superior moisturising and lubricating capability suitable for use as a skin moisturiser or as a lubricant with added protection against harmful organisms .
- the flax husk extract is separated from the husk using a filter and the filtrate liquid is then heated to 80-85 C and maintained at that temperature for 1 to 100 minutes , preferably 5 to 10 minutes ,- to effect the killing of some of the organisms and also to assist the spores that are present in the flax husk extract to germinate .
- stage 3 The flax husk extract from stage 2 or at the end of stage 1 may be preserved with a natural or nature identical preservative such as Cinnamic acid (available under the trade mark Dermasoft 747 from Dr . Straetmans of Germany or the equivalent synthetic material under the trade mark Dermasoft 688 from Dr . Straetmans . )
- the manufacturer ' s recommended conditions such as pH of 5 and below allow heating to 60 C without degradation .
- Any other natural and nature identical preservative capable of withstanding heating to 6OC or higher, for 10 minutes and longer without any maj or degradation of the preservative chosen would be a suitable alternative such as benzoic acid or its salts .
- Another alternative is to leave the extract un-preserved at this stage . 4.
- the extract from stage 2 or 3 is re-heated after allowing it to stand for 1 hour or longer, ideally for 12-24 hours , back to a temperature of 60-95 C, and preferably 70-85 C . This temperature is maintained for 5 to 60 minutes , preferably 8 to 12 minutes, and then cooled down to a suitable temperature for the addition of any other necessary ingredients, such as buffering agents to adjust pH .
- buffering agents such as buffering agents to adjust pH .
- a citric acid/sodium citrate combination or a lactic acid/sodium lactate combination are preferred buffers .
- Other ingredients may be added to make a gel or a lotion .
- Preferred natural and/or nature identical preservative is the Lactoperoxidase based nature identical preservation system sold under the trademark Biovert .
- the Biovert system alone is capable of preserving the flax extract-as an anti-bacterial and anti-viral agent .
- the antibacterial capability of the Lactoperoxidase system can be enhanced by the addition of 0.05 to 0.5% Cinnamic acid . This may be as supplied under the trade mark Dermasoft 688 and ideally added at a level of 0.1-0.25% .
- the Lactoperoxidase based preservative system can be combined with potassium Sorbate, another nature identical preservative, at 0.01 to 1.0% and ideally at 0.1-0.25% .
- Cinnamic acid Dermasoft 688
- potassium Sorbate in any combinations can be added to the Lactoperoxidase system of antibacterial to enhance its capability . It is also possible to combine other suitable nature identical preservatives with the Lactoperoxidase system that are capable of functioning as antibacterial, antifungal or anti-viral agents that are capable of functioning in the pH range of 4-7 and ideally at- pH range of 4.5-6.
- Xanthan gum, and hydroxyethyl cellulose have been found to be suitable thickening agents .
- the extract is combined with appropriate ingredients in known manner .
- the extract may be formed into a lotion or cream, which is found to possess superior moisturising and lubricating capabilities .
- the gel, lotion or cream all have the added benefit of the very effective natural and/or nature identical antibacterial, anti-fungal and anti-viral protection while remaining very mild to the skin and genital area .
- the proposed antibacterial system based on Lactoperoxidase alone or in combination with other natural and nature identical active ingredients is capable of protecting the users from pathogenic organisms found on skin, mouth, lower intestine and vagina as outlined below and hence makes this combination ideal to provide an added protection to users of this combination as a sexual aid to lubricate and protect the user .
- a typical gel according to the invention consists of :
- Flax Husk Extract 1.0% to 98%, typically 75 to 95%
- Biovert - or any other brand of Lactoperoxidase 1-10% typically 0.5- 2.5% based enzyme system of preservation- enzyme and substrate part-
- antioxidant may be added if desired such as
- Vitamin E 0.01-1.0% , typically 0.05-0.2% (any other suitable antioxidant may be used. )
- Polysorbate 80 0.0-3.0% , typically 0.4-1.5% (any other suitable surfactant may be used to disperse the antioxidant if the antioxidant is an oil soluble material .)
- Typical viscosities of flax husks extract can wary from 800cps to 8, 000cps .
- the level of gelling agent (Xanthan Gum) that needs to be added in the next stage will change to reflect- the viscosity of the flax husks extract solution made to give the final desired viscosity .
- Extracted gel solution unpreserved or preserved with Cinnamic acid (or Benzoic acid) can be used to generate lubricant formulation as fluid or gel or varying viscosities .
- Xanthan Gum Keltrol SFT type
- Xanthan Gum can be used to give 6-10, 000cps and at higher levels for example at 1.0 to 1.2% it- will give gels with viscosities of 12-18 , OOOcps .
- Gelling agent Even higher levels of viscosity lubricant gels can be made if desired ⁇
- I f phytic acid is in the formula it can be added at 5OC and below while continuing to cool down
- Viscosity 14 , 867 cps at Temperature 24.7C Final pH adjusted to 4.7
Abstract
Lubricant and moisturiser compositions for topical application comprising an extract of the seed husk of flax (Linum usitatissimum), optionally in combination with one or more antibacterial, anti-fungal and anti-viral active ingredients, are disclosed.
Description
DERMAL LUBRICANT AND MOISTURISER
This invention relates to an improved lubricant and moisturiser for application to the skin generally and particularly to mucous membranes .
Liquid compositions are known which may be applied topically to human skin to act as a lubricant or to moisturise it . Popular compositions contain a stable mixture of components so as to perform both functions . As the aqueous miscibility of the major components differs the combined moisturiser and lubricant compositions need to be stabilised, usually as a gel or as an emulsion and also need additives to ensure long-term stability from oxidation and other forms of deterioration . Known compositions may form a stable base for infections, bacterial or viral, present on skin and can act as a vector for the infection carrying it to other people .
This invention provides a liquid and gel lubricants and moisturiser compositions , which, are stable, and does not carry viral and bacterial infections .
According to the present invention there is provided a lubricant and moisturiser composition for topical application comprising an extract of the seed husk of flax (Linum usitatissimum) .
Also provided is a lubricant and moisturiser composition for topical application comprising an extract of the seed husk of flax (Linum usitatissimum) in combination with one or more natural and/or nature identical antibacterial, anti-fungal and anti-viral active ingredients .
The composition can be used as a lubricant due to the lubricant properties of the flax husk extract . It also has the added advantage of providing protection against potentially transmitted infections . Such transmission can
easily take place where the areas of one or more users to which the lubricant has been applied come in contact, e . g . during sexual relations .
The preferred antibacterial , anti-fungal and anti-viral active ingredient is an antibacterial system based on lactoperoxidase alone or in combination with glucose oxidase and a substrate such as glucose . Such an ingredient is sold under the trademark Biovert . The ingredient is suitably present in a range from 0.5 to 2.5 percent by weight . Preferably the total enzyme levels lie in a range of 0.01 to 0.1 percent by weight .
An alternative antibacterial, anti-fungal and anti-viral active ingredient is Sorbic acid and its sodium and potassium salts . Sorbic acid is suitably present in a range 0.05 to 1.5 percent by weight and preferably in the range 0.1 to 0.5 per cent .
Further antibacterial , anti-fungal and antiviral ingredients include benzoic acid and its sodium and potassium salts . Benzoic acid is suitably present in a range 0.05 to 1.5 percent by weight, preferably 0.1 to 0.5 percent . Cinnamic acid id preferably present in a range 0.05 to 0.4 percent by weight . Salicylic acid or its soluble salts is suitably present in the range 0.1 to 2 percent, more preferably 0.5 to 1 percent . Grapefruit seed extract (sold under a brand name citricidal) in the range of 0.05 to 2.0 percent, more preferably 0.1-0.5 percent .
The formulations made with the flax husk extract may be compounded in known manner to make a gel, a cream or lotions for topical application to skin . For gel preparation xanthan gum, 0.2 to 2 percent by weight, or any other suitable gelling agents such as hydroxy ethyl cellulose or hydroxy propyl ether groups may be added as a gelling agent, to thicken it up to the desired viscosity . The formulations have excellent moisturising and lubricating capability . They are particularly
suitable for use as a lubricant and as a moisturiser on any part of the human body including the lips and genital areas .
The flax husks contain compounds . in colloidal form which, when extracted in cold or hot water, yield colloidal ingredients with unique properties . The extracts are available commercially under the trade marks Natunola flax extract 121 and 141 and 160 from Natunola Health of Canada . However these extracts are preserved with synthetic chemical preservatives .
In the present invention lubricant and moisturiser composition the flax husk extract is preserved using natural and/or nature identical ingredients to control bacteria and also to overcome any fungal spores that may be present in the extract . The preferred natural and/or nature identical antibacterial system is based on Lactoperoxidase . It is able to provide a protective shield to the user of the products from pathogenic bacteria infections such as staphylococcus aureus, widely found on skin and in genital areas, and fungal infections, such as Candida albicans , found mainly in vaginal areas . The Lactoperoxidase is also capable of acting as an anti-viral to give the user of the product a protective shield against these harmful organisms by lowering the population of these organisms by 90% or more within 10 minutes of application and more often within five minutes . It is capable of reducing the population of organisms from several million colony-forming units to a thousand or less colony forming units . This antiseptic property combined with its unique lubricating properties of flax make this combination ideal for use as a sexual aid to give an added protection against potential infections .
Extraction of flax husk can be carried out as outlined below or commercially extracted flax husks could be utilised and preserved using these natural and nature identical preservatives to give flax husks with unique properties with the added benefit
of being naturally preserved yet capable of protecting the skin or genital area from harmful pathogenic organisms .
Examples are provided showing the manufacture of a topical gel , lotion and cream with superior moisturising and lubricating capability suitable for use as a skin moisturiser or as a lubricant with added protection against harmful organisms .
1. ) Harvested flax husk is extracted into water at temperatures between 15-85 C or more preferably into warm water heated to between 45-60 C starting from cold. The flax husk extract produced at this stage will contain bacteria and spores capable of growing to become a potential contaminant .
2. ) The flax husk extract is separated from the husk using a filter and the filtrate liquid is then heated to 80-85 C and maintained at that temperature for 1 to 100 minutes , preferably 5 to 10 minutes ,- to effect the killing of some of the organisms and also to assist the spores that are present in the flax husk extract to germinate .
3. ) The flax husk extract from stage 2 or at the end of stage 1 may be preserved with a natural or nature identical preservative such as Cinnamic acid (available under the trade mark Dermasoft 747 from Dr . Straetmans of Germany or the equivalent synthetic material under the trade mark Dermasoft 688 from Dr . Straetmans . ) The manufacturer ' s recommended conditions such as pH of 5 and below allow heating to 60 C without degradation . Any other natural and nature identical preservative capable of withstanding heating to 6OC or higher, for 10 minutes and longer without any maj or degradation of the preservative chosen would be a suitable alternative such as benzoic acid or its salts . Another alternative is to leave the extract un-preserved at this stage .
4. ) The extract from stage 2 or 3 is re-heated after allowing it to stand for 1 hour or longer, ideally for 12-24 hours , back to a temperature of 60-95 C, and preferably 70-85 C . This temperature is maintained for 5 to 60 minutes , preferably 8 to 12 minutes, and then cooled down to a suitable temperature for the addition of any other necessary ingredients, such as buffering agents to adjust pH . A citric acid/sodium citrate combination or a lactic acid/sodium lactate combination are preferred buffers . Other ingredients may be added to make a gel or a lotion .
5. ) Preferred natural and/or nature identical preservative is the Lactoperoxidase based nature identical preservation system sold under the trademark Biovert . The Biovert system alone is capable of preserving the flax extract-as an anti-bacterial and anti-viral agent . However, the antibacterial capability of the Lactoperoxidase system can be enhanced by the addition of 0.05 to 0.5% Cinnamic acid . This may be as supplied under the trade mark Dermasoft 688 and ideally added at a level of 0.1-0.25% . Alternatively the Lactoperoxidase based preservative system can be combined with potassium Sorbate, another nature identical preservative, at 0.01 to 1.0% and ideally at 0.1-0.25% . Cinnamic acid ( Dermasoft 688 ) and potassium Sorbate in any combinations can be added to the Lactoperoxidase system of antibacterial to enhance its capability . It is also possible to combine other suitable nature identical preservatives with the Lactoperoxidase system that are capable of functioning as antibacterial, antifungal or anti-viral agents that are capable of functioning in the pH range of 4-7 and ideally at- pH range of 4.5-6.
6. ) Other ingredients may be added to the husk extract at stage 4 such as thickening agents . Xanthan gum, and hydroxyethyl cellulose have been found to be suitable thickening agents .
7. ) To turn the extract into a gel for use as a moisturiser or other practical form it is combined with appropriate ingredients
in known manner . The extract may be formed into a lotion or cream, which is found to possess superior moisturising and lubricating capabilities . The gel, lotion or cream all have the added benefit of the very effective natural and/or nature identical antibacterial, anti-fungal and anti-viral protection while remaining very mild to the skin and genital area .
The proposed antibacterial system based on Lactoperoxidase alone or in combination with other natural and nature identical active ingredients is capable of protecting the users from pathogenic organisms found on skin, mouth, lower intestine and vagina as outlined below and hence makes this combination ideal to provide an added protection to users of this combination as a sexual aid to lubricate and protect the user .
++ = nearly 100% + = common +/- = rare potential pathogen
A typical gel according to the invention consists of :
1. ) Flax Husk Extract 1.0% to 98%, typically 75 to 95%
2. ) Sodium Citrate 0.0-5.0% , typically 1-2.5% (any other suitable buffering agent may be used. )
3. ) Citric acid 0.05- 3.0 , typically 0.1-0.35% (any other suitable buffering agent may be used . )
4. ) Xanthan Gum 0.1- 5% , typically 0.3-1.5%
5. ) Biovert - or any other brand of Lactoperoxidase 1-10% , typically 0.5- 2.5% based enzyme system of preservation- enzyme and substrate part-
6. ) Dermasoft 688 0.01-5.0% , typically 0.1-0.3%
7. ) Potassium Sorbate 0.01- 4.0%, typically 0.05-0.5%
Other ingredients such as antioxidant may be added if desired such as
8. ) Vitamin E 0.01-1.0% , typically 0.05-0.2% (any other suitable antioxidant may be used. )
9. ) Polysorbate 80 0.0-3.0% , typically 0.4-1.5% (any other suitable surfactant may be used to disperse the antioxidant if the antioxidant is an oil soluble material .)
The following examples illustrate further compositions according to the invention.
Preparation of Gel solution from Flaxseed Husks . -
This is then used-to make lubricant gel, fluid or for use in making lubricant creams and lotions .
1 ) Into 5 L container add 2.5 L of Demin water . -Wt of water used=2 , 501g
2) Add 20Og of cleaned oil free flax seed husks (Example- Fortigrad grade of Flaxseed husk) : actual wt used= 201g
3 ) Start the stirring process with medium speed.
4) Start the heating process to take it up to 55-600C . and when the temperature is at ~55°C, stop the heating.
5) Keep the solution at ~55-60°C for 10 minutes .
6) Place the mix into single bag of Polyester cotton filter (or any other suitable filtration equipment) and collect the liquid gel solution.
7) Record the weight to obtain the yield= I7858g Viscosity
(spindle 5 speed 5 ) = 4520 cps at 24.8 0C
8 ) Heat the solution to 800C and maintain it at 800C for 10 minutes .
The maximum temperature reached in the next ten minutes . The max temperature=82.7°C
9) The actual time the heating kept between 800C to max temperature was lOmin.
10) Add 0.4% equivalent of Benzoic acid (or 4.6% equivalent of 5.2% of Dermasoft 688 solution to make it 0.24% Dermasoft
688 ) in the Gel solution
11) . Adjust pH so that the pH is between 4.5-5.0.
12) 5.1 g of Citric Acid 30%solution were added to bring pH to 4.71.
13) Viscosity 4, 670 cps; pH=4.7-
Typical viscosities of flax husks extract can wary from 800cps to 8, 000cps . The level of gelling agent (Xanthan Gum) that needs
to be added in the next stage will change to reflect- the viscosity of the flax husks extract solution made to give the final desired viscosity .
5 Example of different natural and nature identical preservations used for formulations of lubricant fluids are summarised below :
LUBRICANT FLUID
Manufacturing instructions :
Extracted gel solution unpreserved or preserved with Cinnamic acid (or Benzoic acid) can be used to generate lubricant formulation as fluid or gel or varying viscosities . At 0.65% Xanthan Gum (Keltrol SFT type) can be used to give 6-10, 000cps and at higher levels for example at 1.0 to 1.2% it- will give gels with viscosities of 12-18 , OOOcps . At higher levels of gelling agent even higher levels of viscosity lubricant gels can be made if desired^
1) Sprinkle in Xanthan Gum into the Gel solution under medium to high speed of mixing . Allow 10 minutes of mixing prior to starting the heating process;
2) Heat the solution to 800C, and maintain it at ' 78-83C for lOmin. Then start the cooling process;
3 ) Premix Natural Vit E and Veremul T-80 add to the mix in point 2 when the temperature is about 700C, whilst continuing the cooling process;
4 ) I f Sorbic acid or sodium benzoate is being added it can be added at this stage ;
5 ) I f phytic acid is in the formula it can be added at 5OC and below while continuing to cool down
6) Once the temperature reached ~34°C and below add salicylic acid if the formula calls for it
7 ) Check and Record pH;
8 ) When the solution is at ~30°C, add Potassium Sorbate if it is part of the formula;
9 ) Add Biovert Part 1 if it is part of the formula and mix for 5 minutes ;
10 ) Add the flavour if it is in the formula at this stage , at ~30 °C or below;
11 ) Check the pH and adjust it to about 4.3-5.2 using Citric acid;
12 ) Add Biovert-enzyme part ( if it is in the formula) and mix thoroughly to ensure uniform mixing .
13 ) Check that the final pH is between 4.3 to 5.2 and record the viscosity .
Typically for fluid is between β-12 , 000cps and for gel is 12- 18 , 000cps . Higher viscosity gels up to 45 , 000cps were made and gave satisfactory lubricating properties .
LUBRICANT GEL- An example formula and manufacturing instructions Is given below : To make lOOOg of product ingredients % (w/w) Wt required Wt used Batch number
(g) (g)
Gel solution 98.25 982 .5.5 982 .4
Preserved with Cinnamic acid
( Dermasoft
688 )
Manufacturing instructions :
1 ) Mix at medium speed Gel solution and xanthan gum (Keltrol SFT . ) for 10 minutes
2 ) Heat the gel solution rapidly while being mixed and raise the temperature to 800C, for lOmin . Maintain the temperature at 78-82C for 10 minutes . Then start the cooling process .
3) Premix Vit E and Veremul T-80 until it is uniform and when the temperature is about 700C, add to the gel solution .
4 ) Check and Record pH . Adjust to 4.5-5.0 using Citric Acid. • 5 ) When the solution is at ~30°C, add Potassium Soxbate .
6) Check the pH . and viscosity (using Spindle 6, Speed 5 ) at
RT : - initial
Viscosity=14 , 867 cps at Temperature 24.7C Final pH adjusted to 4.7
An Example of a Cosmetic Cream using Lubricant gel solution to give smooth feeling to the touch made with Flax seed husks extract preserved with nature identical preservation system is given below
Manufacturing instructions :
1 ) Into a beaker add Water, Glycerine, gel solution, add the required amount of Carbopol while the water phase is s tirring under high speed.
2 ) Heat the water phase to 80-82 ° C until a clear gel solution forms .
3 ) Dissolve Boswellia serrata ( or Frankincence ) in Caprylic Capfic Triglycerides . 4 ) Prepare Oil phase , by combining the Boswellia serrata dissolved in caprylic Capric with the following ingredients- Ceteareth 20 , Cocoa' Butter, Myristyl Myristate and Joj oba Oil 5 ) Heat the oil phase to 80-82 " C . 6) Add the Oil phase to Water phase when the 2 phases reach the same temperature ( 80-82 ° C ) . Stir rapidly and maintain the temperature at about 80 ° C . for 10 min . 7 ) Start the cooling process . Add the Dermasoft 688 ( 5% solution) once the temperature reaches 7 OC and below . 8 ) Slow down the speed of stirring .
■ 9 ) Check and record pH and adj ust that the pH is between 4.9-
5.2 using Citric Acid or sodium citrate . 10 ) Add Citricidal . Check and record final pH, adj ust to 4.9-
5.2. 11 ) Check and record viscosity using spindle 6, speed 5.
For the. above formula the following viscosity and pH were recorded .
Viscosity=171 , 733 cps T ° C=25.9 ° C 22 /07 /05 : viscosity ( spindle 6 , speed 5 ) =188 , 935 cps at T=22.6 ° C
Claims
1. A lubricant and moisturiser composition for topical application comprising an extract of the seed husk of flax
(Linum usitatissimum)
2. A lubricant and moisturiser composition for topical application comprising an extract of the seed husk of flax
(Linum usitatissimum) in combination with, one or more natural and/or nature identical antibacterial , anti-fungal and anti- viral active ingredients .
3. A lubricant and moisturiser composition as claimed in claim
2 , characterised in that the natural and/or nature identical antibacterial, anti-fungal and anti-viral active ingredient is a combination of lactoperoxidase glucose oxidase with a substrate and present in a range from 0.5 to 2.5 percent by weight .
4. A lubricant and moisturiser composition as claimed in claim
3 , characterised in that the total enzyme levels lie in a range of 0.01 to 0.1 percent by weight .
5. A lubricant and moisturiser composition as claimed in claim ' 2 , characterised in that the natural and/or nature identical antibacterial , anti-fungal and anti-viral , active ingredient is Sorbic acid or a potassium or sodium salts thereof a range of 0.05 to 5 percent by weight .
6. A lubricant and moisturiser composition as claimed in claim 5, characterised in that the ingredient is present in a range of 0.1 to 0.5 percent by weight .
7. A lubricant and moisturiser composition as claimed in claim
2, characterised in that the natural and/or nature identical antibacterial, anti-fungal and anti-viral active ingredient is benzoic acid or a potassium or sodium salt thereof a range of 0.05 to 1.5 percent by weight .
8. A lubricant and moisturiser composition as claimed in claim 7 , characterised in that the ingredient is present in a range of 0.2 to 0.5 percent by weight .
9. A lubricant and moisturiser composition as claimed in claim 2 , characterised in that the natural and/or nature identical antibacterial, anti-fungal and anti-viral active ingredient is Cinnamic acid a range of 0.05 to 0.4 percent by weight .
10. A lubricant and moisturiser composition as claimed in claim 9, characterised in that the ingredient is present in a range of 0.1 to 0.25 percent by weight .
11. A lubricant and moisturiser composition as claimed in claim 2 , characterised in that" the natural and/or nature identical antibacterial , anti-fungal and anti-viral active ingredient is salicylic acid or a water-soluble salt thereof in a range of 0.1 to 2 percent by weight .
12. A lubricant and moisturiser composition as claimed in claim
11. characterised in that the ingredient is present in a range of 0.5 to 1 percent by weight .
13. A lubricant and moisturiser composition as claimed in claim 2 , characterised in that the natural and/or nature identical antibacterial , anti-fungal and anti-viral active ingredient is Grapefruit seed extract (example Citricidal ) or a water-soluble salt thereof in a range of 0.05 to 2 percent by weight .
14. A lubricant and moisturiser composition as claimed in claim
13, characterised in that the ingredient is present in a range of 0.1 to 1 percent by weight .
15. A lubricant and moisturiser composition as claimed in any of the preceding claims , characterised in that the composition
is a fluid or a gel and contains from 0.1 to 20 percent by weight of xanthan gum.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0500632.5A GB0500632D0 (en) | 2005-01-13 | 2005-01-13 | Dermal lubricant and moisturiser |
GB0500632.5 | 2005-01-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006075236A1 true WO2006075236A1 (en) | 2006-07-20 |
WO2006075236B1 WO2006075236B1 (en) | 2006-09-14 |
Family
ID=34224523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/000045 WO2006075236A1 (en) | 2005-01-13 | 2006-01-12 | Dermal lubricant and moisturiser |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0500632D0 (en) |
WO (1) | WO2006075236A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008043944A3 (en) * | 2006-10-05 | 2008-11-27 | Silab Sa | Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action |
US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
US9470676B2 (en) | 2014-12-19 | 2016-10-18 | Good Clean Love, Inc. | Systems and methods for bio-matching gels, creams and lotions |
US10195169B2 (en) | 2014-12-19 | 2019-02-05 | Good Clean Love, Inc. | Systems and methods for bio-matching gels, creams and lotions |
US10952979B2 (en) | 2014-12-19 | 2021-03-23 | Good Clean Love, Inc. | Topical fertility promoting product and manufacturing method |
WO2023287364A3 (en) * | 2021-07-16 | 2023-02-16 | Lifestyles Healthcare Pte. Ltd. | Long-lasting lubrication composition |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2167951A1 (en) * | 1996-01-24 | 1997-07-25 | Wuwei Cui | Methods for dehulling of flaxseed, producing flaxseed kernels and extracting lignans and water-soluble fibre from the hulls |
WO2002024145A2 (en) * | 2000-09-19 | 2002-03-28 | Rutgers, The State University Of New Jersey | Antiviral substances from plant cuticular and epicuticular material |
US20030136276A1 (en) * | 2001-12-13 | 2003-07-24 | Wuwei Cui | Process and apparatus for flaxseed component separation |
FR2842732A1 (en) * | 2002-07-25 | 2004-01-30 | Oreal | Cosmetic use of at least one lignan or plant extract containing it in composition for topical application to the skin to prevent or treat dryness of the skin, rough skin and/or dull complexion, and/or for moisturizing or softening skin |
FR2842731A1 (en) * | 2002-07-25 | 2004-01-30 | Oreal | Use of a lignan derivative in a composition for treatment of signs of aging of the skin e.g. loss of firmness, elasticity and tonicity of the skin, and dry skin |
WO2004094443A1 (en) * | 2003-04-22 | 2004-11-04 | Acatris Specialities Holding B.V. | Method for recovering a secondary plant metabolite |
WO2004105715A1 (en) * | 2003-05-30 | 2004-12-09 | Isomers Laboratories Inc. | Cosmetic with flax seed extract as carrier |
-
2005
- 2005-01-13 GB GBGB0500632.5A patent/GB0500632D0/en not_active Ceased
-
2006
- 2006-01-12 WO PCT/IB2006/000045 patent/WO2006075236A1/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2167951A1 (en) * | 1996-01-24 | 1997-07-25 | Wuwei Cui | Methods for dehulling of flaxseed, producing flaxseed kernels and extracting lignans and water-soluble fibre from the hulls |
WO2002024145A2 (en) * | 2000-09-19 | 2002-03-28 | Rutgers, The State University Of New Jersey | Antiviral substances from plant cuticular and epicuticular material |
US20030136276A1 (en) * | 2001-12-13 | 2003-07-24 | Wuwei Cui | Process and apparatus for flaxseed component separation |
FR2842732A1 (en) * | 2002-07-25 | 2004-01-30 | Oreal | Cosmetic use of at least one lignan or plant extract containing it in composition for topical application to the skin to prevent or treat dryness of the skin, rough skin and/or dull complexion, and/or for moisturizing or softening skin |
FR2842731A1 (en) * | 2002-07-25 | 2004-01-30 | Oreal | Use of a lignan derivative in a composition for treatment of signs of aging of the skin e.g. loss of firmness, elasticity and tonicity of the skin, and dry skin |
WO2004094443A1 (en) * | 2003-04-22 | 2004-11-04 | Acatris Specialities Holding B.V. | Method for recovering a secondary plant metabolite |
WO2004105715A1 (en) * | 2003-05-30 | 2004-12-09 | Isomers Laboratories Inc. | Cosmetic with flax seed extract as carrier |
Non-Patent Citations (3)
Title |
---|
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BOTTLER: "Soap substitutes and washing powders", XP002378732, retrieved from STN Database accession no. 1917:13486 * |
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ZAGIBALOV ET AL.: "Parameters for the storage of protein isolates", XP002378733, retrieved from STN Database accession no. 1991:678380 * |
DATABASE WPI Section Ch Week 200349, Derwent World Patents Index; Class B04, AN 2003-515790, XP002379533 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008043944A3 (en) * | 2006-10-05 | 2008-11-27 | Silab Sa | Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action |
EP3744311A1 (en) * | 2006-10-05 | 2020-12-02 | Société Industrielle Limousine d'Application Biologique Dite SILAB | Use of an active ingredient from flax acting on the papillary dermis, for anti-ageing action |
US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
US9470676B2 (en) | 2014-12-19 | 2016-10-18 | Good Clean Love, Inc. | Systems and methods for bio-matching gels, creams and lotions |
US10195169B2 (en) | 2014-12-19 | 2019-02-05 | Good Clean Love, Inc. | Systems and methods for bio-matching gels, creams and lotions |
US10952979B2 (en) | 2014-12-19 | 2021-03-23 | Good Clean Love, Inc. | Topical fertility promoting product and manufacturing method |
US11806325B2 (en) | 2014-12-19 | 2023-11-07 | Vaginal Biome Science, Inc. | Topical fertility promoting product and manufacturing method |
WO2023287364A3 (en) * | 2021-07-16 | 2023-02-16 | Lifestyles Healthcare Pte. Ltd. | Long-lasting lubrication composition |
Also Published As
Publication number | Publication date |
---|---|
WO2006075236B1 (en) | 2006-09-14 |
GB0500632D0 (en) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111096912B (en) | Bicontinuous phase type eye and lip makeup remover and preparation method thereof | |
US20030139307A1 (en) | Sanitizing hand cleanser | |
JP2015178497A (en) | Semi-fluid composition used for lubrication, moisturization, disinfection or sterilization, and method of use thereof | |
JPH07330505A (en) | Antimicrobial composition | |
KR101189344B1 (en) | Self-preserving skin care formulation | |
CN105030610A (en) | Anti-aging composition and preparation method thereof | |
WO2006075236A1 (en) | Dermal lubricant and moisturiser | |
CN106109259B (en) | A kind of shampoo shower cream preventing stink with perspiration | |
WO2017092177A1 (en) | Natural broad-spectrum preservative composition comprising grapefruit seed extract and use thereof | |
JP2017025005A (en) | Antiseptic agent containing emblica officinalis | |
KR102272901B1 (en) | Composition for external application to the skin containing meso-2,3-butanediol as a preservative | |
KR20220058468A (en) | A preservative comprising alkanediol, and caprylyl glyceryl ether or ethylhexyl glycerin for skin external application, and a cosmetic composition comprising the same | |
EP2155158B1 (en) | Personal lubricant composition | |
CN109620758B (en) | Double-layer scalp care composition and preparation method thereof | |
JP2002003330A (en) | Cosmetic | |
KR102456647B1 (en) | A preservative comprising caprylhydroxamic acid, 4'-hydroxyacetophenone, and polyol for skin external application, and a cosmetic composition comprising the same | |
KR102482158B1 (en) | gel composition for disinfection and manufacturing method thereof | |
JP6756156B2 (en) | Oral composition | |
CN114010521A (en) | Antibacterial and antiseptic composition with good taste, oral care solution and preparation method thereof | |
JP6918359B2 (en) | Deodorant composition for axillary odor | |
CN114007651A (en) | Preservative for external preparation for skin, and cosmetic composition and pharmaceutical composition comprising same | |
CN111093619A (en) | Male cleanser and preparation method thereof | |
TW202003007A (en) | A composition containing a Rutaceae plant extract | |
KR102373153B1 (en) | Cosmetic composition having double layer and manufacturing method thereof | |
JP2009167139A (en) | External use composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06703830 Country of ref document: EP Kind code of ref document: A1 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6703830 Country of ref document: EP |